The Diagnostic Neuroimaging group, co-directed by Deborah Yurgelun-Todd, PhD, and Perry Renshaw, MD, PhD, was founded in 2008 as a Utah Science Technology and Research (USTAR) initiative at the University of Utah. The Diagnostic Neuroimaging group is part of the Department of Psychiatry and has strong affiliations with the Salt Lake City VA Healthcare System. The focus of this group is to apply magnetic resonance (MR) methods to develop improved diagnostic paradigms and to guide the development of treatment strategies. Studies within this group apply MR techniques to clarify animal and human clinical models of psychiatric disorders. Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), and functional MRI (fMRI) are used to understand changes in brain chemistry, function, and connectivity as they relate to pathophysiology and treatment.